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on behalf of the European ADHD Guidelines Group (EAGG)Objective: The authors performed meta-analyses of ran-
domized controlled trials to examine the effects of cogni-
tive training on attention-deﬁcit/hyperactivity disorder
(ADHD) symptoms, neuropsychological deﬁcits, and ac-
ademic skills in children/adolescents with ADHD.
Method: The authors searched Pubmed, Ovid, Web of
Science, ERIC, and CINAHAL databases through May 18,
2014. Data were aggregated using random-effects models.
Studies were evaluated with the Cochrane risk of bias tool.
Results: Sixteen of 695 nonduplicate records were
analyzed (759 children with ADHD). When all types of
training were considered together, there were signiﬁcant
effects on total ADHD (standardized mean difference
[SMD] ¼ 0.37, 95% CI ¼ 0.09–0.66) and inattentive
symptoms (SMD ¼ 0.47, 95% CI ¼ 0.14–0.80) for reports
by raters most proximal to the treatment setting (i.e.,
typically unblinded). These ﬁgures decreased substan-
tially when the outcomes were provided by probably
blinded raters (ADHD total: SMD ¼ 0.20, 95% CI ¼ 0.01–
0.40; inattention: SMD ¼ 0.32, 95% CI ¼ 0.01 to 0.66).
Effects on hyperactivity/impulsivity symptoms were notThis article can be used to obtain continuing medical education (CME)
at www.jaacap.org.
Supplemental material cited in this article is available online.
www.jaacap.orgsigniﬁcant. There were signiﬁcant effects on laboratory
tests of working memory (verbal: SMD ¼ 0.52, 95% CI ¼
0.24–0.80; visual: SMD ¼ 0.47, 95% CI ¼ 0.23–0.70) and
parent ratings of executive function (SMD ¼ 0.35, 95%
CI ¼ 0.08–0.61). Effects on academic performance were not
statistically signiﬁcant. There were no effects of working
memory training, speciﬁcally on ADHD symptoms. In-
terventions targeting multiple neuropsychological deﬁcits
had large effects on ADHD symptoms rated by most
proximal assessors (SMD ¼ 0.79, 95% CI ¼ 0.46–1.12).
Conclusion: Despite improving working memory per-
formance, cognitive training had limited effects on ADHD
symptoms according to assessments based on blinded
measures. Approaches targeting multiple neuropsycho-
logical processes may optimize the transfer of effects from
cognitive deﬁcits to clinical symptoms.
Key Words: ADHD, nonpharmacological, working
memory, executive functions, evidence-based psychiatry
J Am Acad Child Adolesc Psychiatry 2015;54(3):164–174.ttention-deﬁcit/hyperactivity disorder (ADHD) is a
childhood-onset condition characterized by perva-A sive patterns of inattention and/or impulsivity-
hyperactivity that often persist into later life.1 Combinations
of pharmacological and psychological approaches are rec-
ommended for its treatment.2 Although medication is efﬁ-
cacious in randomized controlled trials (RCT) in the short/
medium-term and is indicated as the ﬁrst-line treatment
(at least for severe cases2), it has a number of potential
limitations—each affecting some patients. These include the
following: partial response or nonresponse3; possible adverseeffects4; uncertainty about long-term costs and beneﬁts5; poor
adherence6; and negative medication-related attitudes from
patients, parents, or clinicians.7 Psychological treatments such
as behavioral parent training are also widely used. However,
a recent meta-analysis8 found no effects on ADHD symptoms
when only ratings by assessors blind to treatment allocation
were considered.
In recent years, cognitive training has been investigated
as a potential ADHD treatment.9 Building on evidence of
brain plasticity from rehabilitation science and contempo-
rary developmental neuroscience, cognitive training is pre-
mised on the notion that key brain networks implicated in
ADHD can be strengthened, and the cognitive processes
they subserve improved, through controlled exposures to
information processing tasks.10 Thus, it is argued that
cognitive training can reduce ADHD symptoms and
improve functioning by targeting neuropsychological deﬁ-
cits thought to mediate ADHD pathophysiology. In keepingJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 54 NUMBER 3 MARCH 2015
COGNITIVE TRAINING IN ADHDwith the complex nature of ADHD neuropsychology,11
cognitive training approaches have targeted a range of def-
icits (e.g., attentional control, working memory, inhibitory
control). Currently, such training is typically delivered via
computers using adaptive procedures, whereby training task
difﬁculty is automatically increased across sessions to
continually challenge the patient at the boundaries of his or
her competence. This has been shown in neuroimaging
studies to be necessary for sustaining neuronal changes.12,13
The efﬁcacy of cognitive training for ADHDwas addressed
in a meta-analysis of nonpharmacological treatments for
ADHD by Sonuga-Barke et al.14 on behalf of the European
ADHDGuidelines Group (EAGG). Thismeta-analysis focused
solely on RCTs. Importantly, it addressed the issue of blinding
by comparing outcomes rated by individualsmost proximal to
the therapeutic setting (often unblinded and invested in the
patient and/or intervention) and those provided by reporters
judged to be probably blinded. Effects of cognitive training on
ADHD symptoms calculated using unblinded ratings were
highly signiﬁcant (standardizedmeandifference [SMD]¼ 0.64,
95% CI ¼ 0.33–0.95). These effects dropped substantially
(SMD ¼ 0.24) and became statistically nonsigniﬁcant (95%
CI ¼ 0.24 to 0.72) when probably blinded measures were
used. However, these results should be considered as pre-
liminary because only 6 RCTs were included. The authors
concluded that more evidence was required, especially from
trials in which assessments were effectively blinded, before
cognitive training could be supported as an ADHD treatment.
A second meta-analysis by Rapport et al.,9 published more
recently and exploring a wider range of outcomes, found
similar effects. However, compared to Sonuga-Barke et al.,14
this more recent meta-analysis included only 2 additional
peer-reviewed RCTs with outcomes related to ADHD core
symptoms. Moreover, to increase statistical power, Rapport
et al.9 also included non-RCTs and pooled across design types,
making effect size estimates of the effects of cognitive training
on ADHD core symptoms and related neuropsychological
impairment difﬁcult to interpret.
A signiﬁcant number of new RCTs of cognitive training
for ADHD, not available for inclusion in these previous 2
meta-analyses,9,14 have been published in the past 2 years,
reﬂecting the current interest in cognitive training in this
ﬁeld. The greater number of trials now available allows a
much more deﬁnitive estimate of the effects of cognitive
training to be made. In the present article, we update the ﬁrst
EAGG cognitive training meta-analysis to include these new
trials, and we extend its focus to cover effects on neuro-
psychological processes and academic functioning, which
were not addressed in the previous EAGG meta-analysis.14
The focus on neuropsychological processes is important for
2 reasons. First, neuropsychological deﬁcits are postulated to
mediate the pathways between originating causes and dis-
order onset: improvements in neuropsychological func-
tioning may therefore be a prerequisite for ADHD symptom
reduction.15 Second, they are associated with functional
impairments in their own right, independent of their asso-
ciation with ADHD symptomatology, especially in social
and academic contexts.16 A broad range of training ap-
proaches have been used with ADHD populations. In theJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 54 NUMBER 3 MARCH 2015meta-analysis by Sonuga-Barke et al.,14 given the small
number of studies available, trials with different techniques
had to be pooled to generate an effect size estimate. How-
ever, given the increased number of trials now available, our
aim was to explore training-type speciﬁc effects through the
use of subanalyses where sufﬁcient numbers of trials existed.
METHOD
The EAGG protocol for nonpharmacological interventions for
ADHD was registered on the International Prospective Register of
Systematic Reviews PROSPERO (http://www.crd.york.ac.uk/
PROSPERO, protocol number: CRD42011001393). The same proto-
col was followed here.
Inclusion and Exclusion Criteria
Only RCTs including interventions aimed to directly train a cogni-
tive function were retained. As reported by the Cochrane group,17 to
ensure high levels of methodological adequacy and to avoid the
inevitable bias caused by dependence on investigators agreeing to
provide data from unpublished studies, only published studies were
included. Trials were included if participants had an ADHD diag-
nosis (any subtype) or met accepted cut-offs on validated ADHD
rating scales and were between 3 and 18 years of age. Trials
involving children with ADHD comorbid with rare disorders (e.g.,
fragile X syndrome) only were excluded. Control conditions allowed
were “treatment as usual,” “wait list,” “active/placebo/sham” (i.e.,
involving other forms of computer-based activity or alternative
training regimen). Trials were not excluded if patients received
medication as part of normal treatment. In an extension of the
EAGG protocol,14 trials could be included in this updated meta-
analysis despite not reporting an ADHD outcome if they reported
neuropsychological and/or academic outcomes.
Search Strategy
Sonuga-Barke et al.14 included studies up to April 3, 2012. Here,
using the same search strategy, our ﬁnal search date was May 18,
2014. Supplement 1, available online, reports details about the
search strategy and syntax for each database. Parallel searches were
conducted separately by the ﬁrst 2 authors.
Outcome Measures
For consistency with previous EAGG meta-analyses8 and to provide
a robust estimate of effects, outcome domains were analyzed only if
5 or more RCTs were available. The outcomes analyzed were: ADHD
symptoms (total ADHD as well as inattention and hyperactivity/
impulsivity symptoms), parent ratings of executive functioning (e.g.,
Behavior Rating Inventory of Executive Function [BRIEF]), standard-
ized measures of reading and arithmetic ability, and laboratory-based
measures of verbal and visual working memory, inhibition, and atten-
tion. For neuropsychological outcomes, only scores from tasks different
from those used for training were included in the analysis.
Study Selection
Articles’ titles and abstracts were screened independently by the ﬁrst
2 authors. Final inclusion was based on the full text. Trials were
blindly double coded for eligibility by the ﬁrst 2 authors (S.C., M.F).
Disagreement was resolved by the senior author for 3 trials.
Risk of Bias Assessment
Two authors independently assessed trial risk of bias using 5 do-
mains of the Cochrane Collaborations tool17: namely, selection bias,
performance bias, detection bias, attrition bias, and other bias. Ifwww.jaacap.org 165
FIGURE 1 Preferred Reporting Items in Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of selection of studies (last
search updated May 18, 2014). Note: aA total of 259 studies were not on attention-deficit/hyperactivity disorder (ADHD); 342 were
not on cognitive training; 7 were not randomized controlled trials (RCTs); 47 were reviews; 3 were studies in adults; and 1 was a
study protocol. bReasons for exclusion of each study are reported in Table S2, available online. cEgeland et al.24 and Hovik et al.25
refer to the same study.
CORTESE et al.there was disagreement between the 2 raters, the ﬁnal rating was
established through consensus with the involvement of the senior
author. This occurred for 4 trials.Data Extraction and Statistical Analysis
Trial information was entered into RevMan 5.0.18 Data extraction
was independently performed and cross-checked by the ﬁrst 2 au-
thors. SMD was calculated as mean pre- to posttreatment change in
the intervention group minus the mean pre- to posttreatment change
in the control group divided by the pooled pretest standard devia-
tion with a bias adjustment.19 SMDs for each trial were combined
using the inverse variance method. Given the inherent heterogeneity
of studies, random effects models were used. The I2 statistic was
calculated a posteriori to estimate between-trial SMD heterogeneity.
For the most proximal analysis, parent ratings, if available, were
used for home-based interventions, and teacher ratings were used
for school-based interventions, except when it could be inferred
from the manuscript’s text that teachers were less blinded than
parents for home-based interventions and parents less blinded than
teachers for school-based interventions (2 trials20,21). Probably blin-
ded assessments were those made by an individual judged likely to
be unaware of treatment allocation. In trials in which more than 1
such measure was available, the best-blinded measure was chosen.
For home-delivered interventions, teachers’ ratings were usually166 www.jaacap.orgjudged to be blinded, whereas for school-based interventions, par-
ents were judged to be blinded except where this could be inferred
not to be the case from the text20,21 or from e-mail exchange with the
authors. As per protocol, where direct observations were available,
we selected these over rating-scale scores. This decision was based
on the judgement that direct observations are likely, in general, to be
better blinded than parent- or teacher-rated outcomes, even when
the latter are made in a setting other than the therapeutic setting.
Where multiple measures were available for a single outcome (as
was sometimes the case for laboratory tasks), the measure most
frequently reported across included trials and/or that which was
judged to tap the core of the construct was selected. Sensitivity an-
alyses were conducted including only trials meeting the following
criteria: use of active/sham control; use of working memory
training; use of training targeting more than 1 neuropsychological
domain (termed here “multiple process training”); and use of no/
low medication (i.e., with <30% of participants receiving medica-
tions). We also performed an additional sensitivity analysis
excluding the study by Gray et al.,22 in which all participants had a
diagnosis of ADHD plus coexisting intellectual disability. Publica-
tion bias was assessed with funnel plots and Egger’s tests. Finally,
we also conducted a meta-regression analysis, using the metareg
command in STATA,23 to assess the relationship between age and
SMD for most proximal and probably blinded assessments of
ADHD core symptoms. This analysis was conducted to establishJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 54 NUMBER 3 MARCH 2015
TABLE 1 Characteristics of Studies Included in the Meta-Analysis
Trial Design Training Sample Outcomes
First
Author
(Year) Type Control
Length
of
Training
(Days)
and FU Type Setting
n
T
C
Meds
T (%)
C (%) Age (mo)
ADHD
M-Prox
ADHD
P-Blind
Included
Neuropsychology
Outcomes
Academic
Functioning
Klingberg
(2005)26
2 groups NA-WMT 35
FU:
3 mo
WMT
RoboMemo43
School/home 26
27
0a
0
116 (mean) Parent Teacher Digit span (verbal WM);
span board (visual
WM); stroop accuracy
(inhibition)
N/A
Shalev
(2007)27
2 groups Computer
games
56
No FU
Attention training Clinic 20
16
0b
0b
72e156 Parent Parent N/A In-house
tests
Johnstone
(2010)28
2 groups NA-WMT 35
No FU
Inhibitory and WMT Home 20
20
47c
78c
95e149 Parent Parent No go errors %
(inhibition)
N/A
Rabinerd
(2010)29
3 groups Waitlist 98
FU:
within
1 y
Attention training
Captain’s Log44
School/home 25
25e
7 NS Teacher N/A N/A Woodcock-
Johnson
test
Steinerf
(2011)20
3 groups Waitlist 120
No FU
Attention/WMT
BrainTrain44
School 13
15
60 148.8 
10.8
(mean)
Parent Teacher N/A N/A
Tuchag
(2011)30
3 groups Visual
perception
training
28
No FU
Attention training
AixTent
Welfare
service,
home or lab
16
16
100
100
124e138 N/A N/A Vigilance omissions
(inattention)
N/A
Johnstoneh
(2012)31
3 groups Waitlist 35
FU:
6 wk
Adaptive inhibitory
training and WMT
Home 22
20
90 95e145 Parent NA Counting span (verbal
WM); Go NoGo, RT
incongruent stimuli
(inhibition); oddball task
correct (attention)
N/A
Gray
(2012)22
2 groups Adaptive math
training
Academy
of Math
35
No FU
Adaptive WMT
RoboMemo43
School 32
20
98 144e204 Teacher N/A Digit span back (verbal
WM); CANTAB spatial
WM (visual WM); D2
test total (attention)
Wide-Range
Achieve-
ment
Green
(2012)32
2 groups NA-WMT 25
No FU
Adaptive WMT
RoboMemo43
Home 12
14
67
14
84e168 Parent Parent WISC index (verbal WM) N/A
Van der
Oord
(2012)33
2 groups Waitlist 35
FU:
9 wk
Adaptive EF training
(inhibition, WM,
ﬂexibility)
Home 18
22
66 96e144 Parent Teacher N/A N/A
Tamm
(2013)34
2 groups Waitlist 56
No FU
Adaptive attention
training
Pay Attention!
School 45
46
65
73
84e180 Parent Clinician Digit span (verbal WM);
D-KEFS scaled score
(inhibition), omissions
(inhibition)
N/A
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TABLE 1 Continued
Trial Design Training Sample Outcomes
First
Author
(Year) Type Control
Length
of
Training
(Days)
and FU Type Setting
n
T
C
Meds
T (%)
C (%) Age (mo)
ADHD
M-Prox
ADHD
P-Blind
Included
Neuropsychology
Outcomes
Academic
Functioning
Chacko
(2013)35
2 groups NA-WMT 35
No FU
Adaptive WMT
RoboMemo43
Home 44
41
27
32
84e132 Parent Teacher AWMA listening (verbal
WM); dot matrix (visual
WM); CPT commissions
(inhibition); omissions
(attention)
Wide-Range
Achieve-
ment
Egelandi
(2013)24
2 groups TAU 25
FU:
8 mo
Adaptive WMT
RoboMemo43
School 33
34
68 120e144 Teacher N/A Stroop interference score
(inhibition; CPT focus
(attention)
Logos Test
Hovik (2013)25 2 groups TAU 25
FU:
8 mo
Adaptive WMT
RoboMemo43
School 33
34
68 120e144 Teacher N/A Digit span (verbal WM);
Leiter visual span
(visual WM)
N/A
Steinerf
(2014)21
3 groups
(neurofeed-
back,
cognitive
training,
control)
TAU 91
No FU
Adaptive attention
and WMT
School 34
36
41
55
100.8 
14.8
(mean)
Parent Direct
observa-
tion
(BOSS)
N/A N/A
Van Dongen-
Boomsma
(2014)36
2 groups NA-WMT 35
No FU
Adaptive WMT
(Cogmed
RoboMemo43)
Home, except
for 1
participant
26
21
0
0
71.5e87.6 Investigator Teacher Digit span (verbal WM);
Knox Cubes (visual
WM); Stroop difference
(inhibition); Sustained
attention dots: SDRT
(attention)
N/A
Note: Studies are listed in chronological order of publication and are followed by study reference number, as in Table S1, available online; long-term follow-up is listed under “Length of Training” after first outcome
measurement when available, and “n” is the number of individuals in the treatment (T) and control (C) conditions. ADHD ¼ attention-deficit/hyperactivity disorder; AWMA ¼ automated working memory assessment;
BOSS ¼ Behavioral Observation of Students in Schools; CANTAB ¼ Cambridge Neuropsychological Test Automated Battery; D-KEFS ¼ Delis-Kaplan Executive Function System; EF ¼ executive functions; FU ¼ follow-up;
MProx ¼ most proximal rater; N/A ¼ not applicable; NA-WMT ¼ non-adaptive working memory training; NS ¼ not specified; PBlind ¼ probably blinded rater; RT ¼ reaction time; SDRT ¼ Spatial Delayed Response
Task; TAU ¼ treatment as usual; WISC ¼ Wechsler Intelligence Scale for Children; WMT ¼ working memory training.
aTwo children discontinued stimulants more than 1 year before the study, 1 child discontinued stimulant medication 1 week before the study, and the other participants were stimulant naive.
bFour participants in the treatment group and 3 in the control group received psychostimulants throughout the duration of the study. None were medicated either during the training sessions or during the pre- and posttesting
sessions.
cParticipants were asked to refrain from taking ADHD medication in the 24 hours before testing.
dThis study also included an arm on computer-assisted instruction that was not considered for the present meta-analysis.
eA total of 27 additional participants were allocated to computer-assisted instruction.
fThis trial also included an arm of neurofeedback (www.playattention.com).
gResults of this study are also reported in Lange KW, Tucha L, Hauser J, Lange KM, Stasik D, Tucha O. Attention training in attention deficit hyperactivity disorder. Aula Abierta 2012;40:55-60.
hThis study also included a “software with attention monitoring” arm, which was not included in the present meta-analysis for consistency with interventions included in the other studies retained in the meta-analysis.
iThis paper and Hovik et al.14 refer to the same study and present analyses on different outcomes.
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COGNITIVE TRAINING IN ADHDwhether the efﬁcacy of cognitive training varied across age, a
ﬁnding that could be of clinical signiﬁcance.
RESULTS
Fifteen trials (reported in 16 papers) met entry criteria (see
Table S1, available online). Studies not included in the meta-
analysis are listed (with reasons for their exclusion) in
Table S2 (available online). Figure 1 reports the trial selection
ﬂowchart. Table 1 gives information about retained trials.
Results of all analyses are summarized in Table 2. Six trials
were on working memory training, 4 on attention training, 2
combined attention and working memory training, 2 inhibi-
tion and working memory training, and 1 trial provided a
general executive function training covering working mem-
ory, inhibition, and cognitive ﬂexibility. All training schedules
had an “adaptive” component, that is, task difﬁculty was
increased across sessions to track performance improvement.
Eight trials had an active control condition. Six trials were
implemented at home, 5 at school, 2 at either school or home,TABLE 2 Summary of Results Showing Pooled Standardized Mean
Each Outcome
Outcome Trials Included Measure S
ADHD total All MProx
PBlind
Active control MProx
PBlind
WMT MProx
MPT MProx
MED MProx
PBlind
Inattention All MProx
PBlind
Active control MProx
WMT MProx
MED MProx
Hyper/Imp All MProx
PBlind
Active control MProx
WMT MProx
Executive function rating All MProx
Working memory (visual) All Objective
Active control Objective
WMT Objective
Working memory (verbal) All Objective
Active control Objective
WMT Objective
Inhibition All Objective
Attention All Objective
Reading All Standardized tests
Arithmetic All Standardized tests
Note: Significant effects are expressed in boldface. Table reports only measures for w
reported, there were insufficient trials with probably blinded rater (PBlind) measures.
training; ADHD ¼ attention-deficit/hyperactivity disorder; All ¼ all trials meeting incl
were treated with ADHD medication; MPT ¼ multiple process training; WMT ¼ al
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center, home or laboratory. Five trials had no/lowmedication
levels. Figure S1 (available online) depicts the graphic output
for the risk of bias assessment. Risk of bias was generally low
or unclear. No trials were scored as “high risk”with regard to
“random sequence generation,” “allocation concealment,”
and “incomplete outcome data,” and only 3 and 4 trials
scored high for “blinding of participants/personnel” and
“blinding of outcome assessment,” respectively (the rating of
each study is available upon request).
ADHD Symptoms
ADHDsymptoms (total score or inattention or hyperactivity/
impulsivity separately) were an outcome in up to 14 trials.
Probably blinded measures were available in up to 11 trials
(Table 2).
When most proximal assessments were the outcome, there
was a moderate but signiﬁcant effect on total ADHD and in-
attention symptomsbutnoeffectonhyperactivity/impulsivityDifferences (SMD) Between Treatment and Control Arms for
tudy n
Effect Heterogeneity
SMD 95% CI p I2 p
14 0.37 0.09 to 0.66 .01 71 <.001
11 0.20 0.01 to 0.40 .04 30 .16
7 0.16 0.23 to 0.55 .41 71 <.001
6 0.22 0.09 to 0.53 .17 42 .13
6 0.00 0.31 to 0.31 1.00 56 .05
5 0.79 0.46 to 1.12 <.001 36 .18
5 0.19 0.16 to 0.54 .30 56 .06
5 0.11 0.10 to 0.32 .31 0 .74
11 0.47 0.14 to 0.80 <.01 76 <.001
9 0.32 0.01 to 0.66 .06 69 <.001
5 0.30 0.17 to 0.76 .21 72 <.001
5 0.22 0.18 to 0.62 .28 66 <.001
5 0.35 0.09 to 0.79 .29 71 .02
9 0.14 0.07 to 0.35 .18 28 .28
8 0.18 0.01 to 0.37 .06 0 .50
5 0.01 0.25 to 0.22 .91 0 .60
5 0.02 0.24 to 0.21 .89 0 .68
6 0.35 0.08 to 0.61 .01 22 .22
5 0.47 0.23 to 0.70 <.01 69 <.001
Insufﬁcient trials (n ¼ 4)
5 0.47 0.23 to 0.70 <.01 69 <.001
8 0.52 0.24 to 0.80 <.01 48 .06
5 0.58 0.23 to 0.94 .001 45 .12
6 0.57 0.29 to 0.82 <.001 32 .19
6 0.07 0.15 to 0.28 .53 2 .4
7 0.14 0.19 to 0.48 .41 58 .03
5 0.09 0.09 to 0.27 .33 23 .26
5 0.01 0.13 to 0.11 .84 0 .44
hich 5 or more trials were available. Where only most proximal rater (MProx) is
Active controls ¼ all trials with an active control arm such as easy or non-adaptive
usion criteria with available measure; MED ¼ trials in which <30% of participants
l trials using just working memory training.
www.jaacap.org 169
CORTESE et al.(Figure 2; SMD and CI data for all outcomes are presented in
Table 2). In sensitivity analyses (Figures S2 and S3, available
online), considering only trials with an active control, the
effects were no longer statistically signiﬁcant for any ADHD
core symptoms outcomes. There was no effect of working
memory training when implemented on its own (Figures S2
and S3, available online). In contrast, multi-process training
approaches (i.e., approaches targeting more than 1 neuropsy-
chological domain) gave a large effect size for total ADHD
symptoms (Figure S2, available online). Between-study
heterogeneity of effect sizes was high and signiﬁcant for total
ADHD and inattention symptoms.
When analyses were restricted to probably blinded
measures (Figure 2), in general, effect sizes were reduced
with small and statistically marginal effects for all ADHD
outcomes. In a sensitivity analysis (Figure S4, available on-
line), effect sizes dropped further to nonsigniﬁcant levels
when only trials with an active control arm were included.
There were insufﬁcient studies (n < 5) for an analysis of
probably blinded measures in multi-component training
trials, as well as for a number of other sensitivity analyses.
When analysis was restricted to no/low medication trials,
effects on total ADHD symptomswere not signiﬁcant for either
most proximal or, when available, probably blinded assess-
ments in any ADHD core symptom–related outcome (Table 2).
Neuropsychological Outcomes
Eight trials included laboratory measures of verbal, and 5
trials visual working memory (Table 2). There was a largeFIGURE 2 Forest plots for meta-analysis of effects on attention-de
by the most proximal and probably blinded raters. Note: Cogn ¼ c
170 www.jaacap.organd signiﬁcant effect of cognitive training on both compo-
nents (Figure 3), which was maintained in sensitivity ana-
lyses considering trials with active controls only or working
memory training trials only (Figure S5, available online;
sensitivity analyses were not performed for visual working
memory because of an insufﬁcient number of trials). The
number of trials using multi-component training and no/
low medication trials was insufﬁcient to perform sensitivity
analyses. There were no signiﬁcant effects of training on
laboratory tests of inhibition (6 trials) or attention (7 trials)
(Figure 3). Six trials included most proximal ratings of ex-
ecutive functioning using the BRIEF rating scale (Figure S6,
available online). These demonstrated a small-to-moderate,
signiﬁcant SMD. There was an insufﬁcient number of trials
with ratings of executive functioning to perform planned
sensitivity analyses.Academic Ability
Five trials included standardized measures of reading and 5
of arithmetic. There were no signiﬁcant effects in either
domain (Figure 3). There was an insufﬁcient number of trials
to perform planned sensitivity analyses.Publication Bias
Funnel plots and results of Egger’s test are reported in
Supplement 2 (available online). For both meta-analyses of
ADHD symptoms scored by most proximal and probablyficit/hyperactivity disorder (ADHD) core symptoms assessed
ognitive; std ¼ standard.
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FIGURE 3 Forest plots for meta-analysis of effects on neuropsychological and academic outcomes. Note: Cogn ¼ cognitive;
std ¼ standard.
COGNITIVE TRAINING IN ADHDblinded raters, the test failed to reach the p < 0.05 level,
suggesting no signiﬁcant publication bias.
Meta-Regression Analysis
For most proximal or probably blinded assessments of
ADHD core symptoms, there was no signiﬁcant effect of age
on SMD (see Supplement 3, available online).
Sensitivity Analysis Excluding the Study by Gray et al.22
The main results considering most proximal assessment of
ADHD core symptoms were substantially unchanged, as
reported in Figure S7 (available online). As this study was
not included in “probably blinded” analyses, no sensitivity
analysis was conducted considering probably blinded
assessment.
DISCUSSION
There are 2 perspectives on cognitive training in ADHD.
From 1 perspective, cognitive training is a front-line ADHD
treatment: this is based on the hypothesis that because causal
pathways to disorder are mediated by neuropsychological
deﬁcits, strengthening deﬁcient neuropsychological functions
should reduce ADHD symptoms and associated impairment.
From the second perspective, it is perceived as an adjunctive
treatment that reduces impairment associated with neuro-
psychological deﬁcits commonly seen in children with
ADHD, independent of any effects on core ADHD symptoms
itself. The current meta-analysis, including an additional 10JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 54 NUMBER 3 MARCH 2015RCTs compared to the previous study by Sonuga-Barke
et al.,14 provided little support for cognitive training as a
front-line ADHD treatment. There were statistically signiﬁ-
cant effects on ADHD symptoms when considering raters
most proximal to treatment delivery, especially for symp-
toms of inattention. However, these effects were reduced
substantially when analyses were limited to trials with an
active control arm or where assessors were probably blind to
treatment allocation. The evidence was somewhat stronger
for the beneﬁts of cognitive training as an adjunctive treat-
ment aimed at reducing neuropsychological impairment.
There were large and highly signiﬁcant improvements on
objective tests of both visual and verbal working memory,
although there were no effects on inhibition or inattention.
Furthermore, the effects of cognitive training on working
memory did not extend to the academic outcomes explored.
The substantial drop in SMDs between most proximal
and probably blinded analyses for ADHD symptoms is
similar to the pattern seen in previous meta-analyses of
nonpharmacological treatments using the EAGG protocol
(e.g., behavioral intervention;8 neurofeedback14). This is
probably caused by the inﬂation of effect size estimates that
inevitably occurs when one relies on raters who are both
likely to be aware of treatment allocation and heavily
invested in the delivery and outcome of treatment. It is also
possible that probably blinded and most proximal assess-
ments differed in some way that reduced the sensitivity of
the former to treatment-related change. However, the same
measurement approaches were used for each (some parent,www.jaacap.org 171
CORTESE et al.some teacher, and some direct observation measures).
Another possibility is that most proximal assessments
accurately captured treatment effects established in the
therapeutic setting but that these effects did not generalize to
the settings in which probably blinded assessments were
made. However, in a substantial minority of trials (Table 1),
especially those with an active control arm, probably blin-
ded measures were collected in the treatment setting, and
the effects for these trials were no larger than those for trials
in which they were collected in a different setting.
The trials included in the meta-analysis used a wide
range of training approaches targeting different neuropsy-
chological processes. There was a sufﬁcient number of trials
to look at 2 classes of intervention individually, which was
not possible in the previous meta-analysis by Sonuga-Barke
et al.14: namely, training of working memory only, and
training focusing on multiple neuropsychological domains.
The results for trials implementing working memory
training only departed in a striking way from the most
proximal/probably blinded pattern described above. Effects
on ADHD were negligible even considering most proximal
measures. This suggests that this form of training, which has
been widely promoted for use with patients with ADHD (as
discussed by Rapport et al.,9), has little or no efﬁcacy for core
ADHD symptoms. On the other hand, the SMD for most
proximal assessment of ADHD symptoms was substantially
larger for trials based on training targeting multiple domains
than for all studies as a whole. Unfortunately, there was an
insufﬁcient number of trials (n ¼ 4) with probably blinded
measures to corroborate these effects using independent
sources. The superiority of these approaches may be due to
the typically greater number of training sessions in multi-
compared to single-component approaches (in our analysis,
an average of 9 weeks compared to 6 weeks, respectively).
However, the ﬁnding opens up the interesting possibility that
multi-component training models may be more successful for
ADHD, given the complex and heterogeneous nature of the
condition. Because children with ADHD differ from one
another in their neuropsychological proﬁle, and because
children may be affected by more than 1 deﬁcit,37,38 multi-
component training may be used to target a series of neuro-
psychological domains that may be more important than
working memory alone in the pathophysiology of ADHD
symptoms. The development and evaluation of multi-
component training models should be a future priority.
The effects on neuropsychological outcomes were
restricted to working memory, which were substantial, with
no effects on inhibitory or attentional control. There were
signiﬁcant effects on parents’ ratings of executive function,
but these could not be corroborated by independent blinded
evidence. All 6 trials that included a working memory
outcome were working memory training trials. Therefore,
although these trials produced “near transfer” of training
effects to untrained working memory measures, there was
no evidence of “far transfer” to other neuropsychological
processes. Crucially, there was also no evidence that these
effects generalized to important areas of everyday func-
tioning, which themselves are inﬂuenced by working
memory ability,16 such as reading and arithmetic. This172 www.jaacap.orgﬁnding may be relevant in clinical practice. Indeed, parents
may currently favor cognitive training with the hope that
they can improve academic performance. Our results show
that this is not supported by empirical evidence.
The success of working memory training in improving
working memory performance draws into even sharper re-
lief its failure to improve ADHD symptoms, suggesting
dissociation between neuropsychological functioning and
disorder. There are 4 possible explanations for this: ﬁrst, that
working memory deﬁcits do not, in fact, mediate ADHD
pathophysiology39; second, that although they do mediate
the development of ADHD, they have become entrenched
and not susceptible to the type of training implemented in
trials conducted to date; third, that training as currently
implemented targets types of working memory not funda-
mental to the deﬁcits in ADHD9; and fourth, that training
produces only peripheral, practice-like effects on working
memory, with no profound impact on the brain networks
underpinning neuropsychological deﬁcits responsible for
ADHD. Whether or not working memory deﬁcits are part of
the causal mechanism underpinning ADHD, based on our
results, strengthening working memory appears to be
neither a necessary nor a sufﬁcient condition for ADHD
symptom reduction. In this regard, our ﬁndings suggest that
choosing substrates that have emerged from experimental
research as treatment targets may not necessarily translate
into clinical beneﬁts. This possible dissociation between
candidate mechanisms of a disorder and clinical targets is
important when adopting pathophysiology-based research
approaches such as the Research Domain Criteria (RDoC).40
From a clinical standpoint, developing techniques to extend
transfer from the effects on core working memory processes
to broader neuropsychological processes and important
domains of impairment and/or clinical presentation is the
most pressing challenge for the future. The reasons for the
lack of effect on inhibitory and attentional control are hard to
determine on the basis of the current analysis, given the
small number of trials that speciﬁcally targeted these do-
mains. Although we might predict that training targeting
multiple deﬁcit domains would show effects on these neu-
ropsychological processes, there were insufﬁcient trials with
multi-component training and measures of inhibition and/
or attention to test this. Approaches focusing on motiva-
tional or energetic processes may also be valuable (i.e.,
training to increase delay of gratiﬁcation).41
Anumber of limitations need tobe taken into accountwhen
interpreting the current analysis. First, there was signiﬁcant
SMD heterogeneity for some analyses (most proximal total
ADHD, symptoms of inattention, and visual working mem-
ory). This leaves open the possibility that cognitive training
may be effective under speciﬁc circumstances in individual
trials. Given the limited number of trials available, we were
unable to identify speciﬁc features of positive trials (apart from
therapeutic content, working memory training). Second, only
a minority of trials (n ¼ 5) reported using intention-to-treat
analyses, a situation that may have inﬂated the effects for
some outcomes, as participants who are more difﬁcult to treat
or who perceive the treatment as less beneﬁcial may drop out
of trials; however, drop-out was relatively low in most trials.JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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COGNITIVE TRAINING IN ADHDThird, despite the recent substantial increase in the number of
available cognitive training trials, there was an insufﬁcient
number of trials to evaluate training approaches targeting
speciﬁc neuropsychological constructs other than working
memory training. Fourth, there were insufﬁcient trials to run
analyses for some important outcomes (e.g., functional
impairment, IQ), as well as for sensitivity analyses or analyses
restricted to probably blinded measures for a number of out-
comes. Fifth, too few trials included long-term outcomes
(Table 1) to allowanevaluationof the extent towhich effects on
clinical symptoms grew over time or effects on neuropsycho-
logical processes persisted. Sixth, no trials were restricted to
individuals with both ADHD and the speciﬁc neuropsycho-
logical deﬁcit to be trained. As a consequence, effect sizes for
both neuropsychological deﬁcits and ADHD symptoms may
havebeen truncated: in the former case because therewouldbe
little room for improvement where no deﬁcit existed; in
the latter case because targeting a neuropsychological deﬁcit
thatwasnot causing the conditionwouldbeunlikely to reduce
symptoms of the core condition. Seventh, in the neuropsy-
chological domains, diversemeasures fromdifferent tasks (still
tapping the same domain, however) were combined across
studies to allow the calculation of pooled SMD estimates.
Eighth, it is important to understandwhether initial symptom-
related and neuropsychological treatment effects persist over
time and generalize to other domains, if they do. There were
insufﬁcient trials that examined long-term outcomes to
address this issue. Finally, the categorization of studies as
“probably blinded,” although carried out according to previ-
ously agreed and clear decision rules set out in the protocol, is
limited by an inevitable degree of uncertainty because of lim-
itations in the information reported in some trials.
In summary, the current meta-analysis found limited
evidence for the clinical value of cognitive training for chil-
dren with ADHD outside of the narrow conﬁnes of speciﬁc
targeted neuropsychological processes (i.e., working mem-
ory training improved working memory function). Given the
evidence for neuropsychological heterogeneity in ADHD,
future efforts should be directed at developing protocols to
target a broader range of neuropsychological deﬁcits.
Furthermore, therapeutic innovation is required to enhance
the “far transfer” of speciﬁc neuropsychological gains to
everyday patterns of functional impairment through more
ecologically valid training approaches.42 Future trials should
more consistently include active control arms, a broader
range of functional outcomes, and long-term follow-up. &JO
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